Prevention of early onset group B streptococcal disease by universal antenatal culture-based screening in all public hospitals in Hong Kong

References

• Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease – revised guidelines from CDC, 2010. MMWR Recomm Rep 2010;59:1–36.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Active bacterial core surveillance report, emerging infectious program network, group B streptococcus; 2014. Available from: http://www.cdc.gov/abcs/reports-findings/survreports/gbs14.pdf [last accessed 17 Apr 2016].
   Google Scholar
• Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev 2014;6:CD007467.
   PubMed Web of Science ®Google Scholar
• Eastwood KA, Craig S, Sidhu H, et al. Prevention of early-onset Group B Streptococcal disease – the Northern Ireland experience. BJOG 2015;122:361–7.
   PubMed Web of Science ®Google Scholar
• Schrag SJ1, Verani JR. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine 2013;31:D20–6.
   PubMed Web of Science ®Google Scholar
• Darlow BA, Voss L, Lennon DR, Grimwood K. Early-onset neonatal group B streptococcus sepsis following national risk-based prevention guidelines. Aust NZ J Obstet Gynaecol 2016;56:69–74.
   PubMed Web of Science ®Google Scholar
• Hughes RG, Brocklehurst P, Heath P, Stenson B. Prevention of early onset neonatal group B streptococcal disease. Royal College of Obstetricians and Gynaecologists Guidelines No. 36; 2003.
   Google Scholar
• Centers for Disease Control and Prevention. Active bacterial core surveillance report, emerging infectious program network, group B streptococcus; 2011–2012. Available from: http://www.cdc.gov/abcs/reports-findings/survreports/gbs11.pdf [last accessed 17 Apr 2016].
   Google Scholar
• Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000;342:15–20.
   PubMed Web of Science ®Google Scholar
• De Luca C, Buono N, Santillo V, et al. Screening and management of maternal colonization with Streptococcus agalactiae: an Italian cohort study. J Matern Fetal Neonatal Med 2016;29:911–15.
   PubMed Web of Science ®Google Scholar
• Verani JR, Spina NL, Lynfield R, et al. Early-onset group B streptococcal disease in the United States: potential for further reduction. Obstet Gynecol 2014;123:828–37.
   PubMed Web of Science ®Google Scholar
• Van Dyke MK, Phares CR, Lynfield R, et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 2009;360:2626–36.
   PubMed Web of Science ®Google Scholar
• Leung KY, Ma TWL, To KKW, et al. Screening for Group B Streptococcus in pregnancy. JPOG 2012 March/April:81–7.
   Google Scholar
• Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002;51:1–22.
   PubMedGoogle Scholar
• Yancey MK, Schuchat A, Brown LK, et al. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996;88:811–15.
   PubMed Web of Science ®Google Scholar
• Boyer KM, Gotoff SP. Strategies for chemoprophylaxis of GBS early-onset infections. Antibiot Chemother (1971) 1985;35:267–80.
   PubMedGoogle Scholar
• Fairlie T, Zell ER, Schrag S. Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease. Obstet Gynecol 2013;121:570–7.
   PubMed Web of Science ®Google Scholar
• Phares CR, Lynfield R, Farley MM, et al. Active Bacterial Core surveillance/Emerging Infections Program Network. Epidemiology of invasive group B streptococcal disease in the United States, 1999–2005. JAMA 2008;299:2056–65.
   PubMed Web of Science ®Google Scholar
• Schrag SJ, Zell ER, Lynfield R, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002;347:233–9.
   PubMed Web of Science ®Google Scholar
• Tsui MH, Ip M, Ng PC, et al. Change in prevalence of group B Streptococcus maternal colonisation in Hong Kong. Hong Kong Med J 2009;15:414–19.
   PubMedGoogle Scholar
• Kwatra G, Cunnington MC, Merrall E, et al. Prevalence of maternal colonisation with group B streptococcus: a systematic review and meta-analysis. Lancet Infect Dis 2016;16:1076–84.
   PubMed Web of Science ®Google Scholar
• Berardi A, Rossi C, Bacchi Reggiani ML, et al. An area-based study on intrapartum antibiotic prophylaxis for preventing group B streptococcus early-onset disease: advances and limitations. J Matern Fetal Neonatal Med. [Epub ahead of print]. doi: http://dx.doi.org/10.1080/14767058.2016.1224832.
   Web of Science ®Google Scholar
• Szymusik I, Kosinska-Kaczynska K, Krolik A, et al. The usefulness of the universal culture-based screening and the efficacy of intrapartum prophylaxis of group B Streptococcus infection. J Matern Fetal Neonatal Med 2014;27:968–70.
   PubMed Web of Science ®Google Scholar
• Daniels JP1, Gray J, Pattison HM, et al. Intrapartum tests for group B streptococcus: accuracy and acceptability of screening. BJOG 2011;118:257–65.
   PubMed Web of Science ®Google Scholar
• de Tejada BM, Pfister RE, Renzi G, et al. Intrapartum Group B streptococcus detection by rapid polymerase chain reaction assay for the prevention of neonatal sepsis. Clin Microbiol Infect 2011;17:1786–91.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Dangor Z, Heath PT, et al. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide–protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. Vaccine 2013;31:D52–7.
   PubMed Web of Science ®Google Scholar
• Colbourn T, Asseburg C, Bojke L, et al. Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses. Health Technol Assess 2007;11:1–226.
   PubMed Web of Science ®Google Scholar